No matter how cynical the overall market is, Standard BioTools Inc (LAB) performance over the last week is recorded 17.14%

A new trading day began on Monday, with Standard BioTools Inc (NASDAQ: LAB) stock price up 17.14%% from the previous day of trading, before settling in for the closing price of $1.05. LAB’s price has ranged from $0.92 to $2.41 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 11.61% over the last five years. Meanwhile, its annual earnings per share averaged 55.47%. With a float of $365.93 million, this company’s outstanding shares have now reached $379.09 million.

The firm has a total of 818 workers. Let’s measure their productivity. In terms of profitability, gross margin is 47.04%, operating margin of -82.21%, and the pretax margin is -78.07%.

Standard BioTools Inc (LAB) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Standard BioTools Inc is 3.66%, while institutional ownership is 72.28%. The most recent insider transaction that took place on May 23 ’25, was worth 1,344. In this transaction Chief Financial Officer of this company sold 1,428 shares at a rate of $0.94, taking the stock ownership to the 930,286 shares. Before that another transaction happened on May 23 ’25, when Company’s SVP & Chief Business Officer sold 13,217 for $0.94, making the entire transaction worth $12,437. This insider now owns 843,076 shares in total.

Standard BioTools Inc (LAB) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 55.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 66.44% during the next five years compared to 11.61% growth over the previous five years of trading.

Standard BioTools Inc (NASDAQ: LAB) Trading Performance Indicators

Here are Standard BioTools Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.75.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.15 in one year’s time.

Technical Analysis of Standard BioTools Inc (LAB)

Analysing the last 5-days average volume posted by the [Standard BioTools Inc, LAB], we can find that recorded value of 5.19 million was better than the volume posted last year of 1.79 million. As of the previous 9 days, the stock’s Stochastic %D was 44.37%.

During the past 100 days, Standard BioTools Inc’s (LAB) raw stochastic average was set at 41.61%, which indicates a significant increase from 40.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.17% in the past 14 days, which was higher than the 81.28% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.0979, while its 200-day Moving Average is $1.5178. Now, the first resistance to watch is $1.4800. This is followed by the second major resistance level at $1.7300. The third major resistance level sits at $1.8700. If the price goes on to break the first support level at $1.0900, it is likely to go to the next support level at $0.9500. Now, if the price goes above the second support level, the third support stands at $0.7000.

Standard BioTools Inc (NASDAQ: LAB) Key Stats

With a market capitalization of 467.18 million, the company has a total of 379,822K Shares Outstanding. Currently, annual sales are 174,430 K while annual income is -138,890 K. The company’s previous quarter sales were 40,800 K while its latest quarter income was -26,030 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.